 |
 |
|
|
|
| Entecavir 209216-23-9 |
 |
| Entecavir 209216-23-9 |
 |
Pharmaceutical Use |
 |
Entecavir 209216-23-9
CAS: 209216-23-9
Assay: 99% min.
Packing: 200g/foil bag.
Character: White crystalline powder. Melting point 249-252℃.
Usage: Antiviral pharmaceutical, Grace for the treatment of hepatitis B virus infection of a new generation of guanine nucleoside analogues entecavir is an oral medication for the treatment of adults with viral replication active and serum transaminases continued to increase, or liver histology with active lesions of chronic hepatitis Bhepatitis, down the virus fastest strongest variation of the lowest risk of nucleoside analogues.
|
|
|
|
|
|
